Exploratory clinical trial of total skin irradiation for primary cutaneous lymphoma using helical TomoTherapy.

Exploratory clinical trial of total skin irradiation for primary cutaneous lymphoma using helical TomoTherapy. - Exploratory clinical trial of total skin irradiation using helical TomoTherapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022142

Enrollment

Registered

2016-06-15

Start date

2016-06-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary cutaneous lymphoma

Interventions

Total skin irradiation using helical tomotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a) Patients with primary cutaneous lymphoma b) Poor controled patients in the tumor phase. c) Patients with written informed consent. d) Age: 20 and older e) PS(performance status): 0-2 f) Patients accepted treatment of TSI g) WBC: 2,000/mm3 and more Platelet: 70,000/mm3 and more Hb: 10 g/dL and more GOT, GPT: less than three times the upper limit of normal T.Bil: 1.5 mg/dL or less

Exclusion criteria

Exclusion criteria: a) Patients with serious complication b) Patients who can not keep their body position c) Patients with technology problems for TSI using tomotherapy d) Patients in pregnancy and lactating woman e) Patients who are considered inadequacy for the trial

Design outcomes

Primary

Measure	Time frame
The frequency of acute adverse event within three months after TSI.	—

Countries

Japan

Contacts

Public ContactKae Okuma

The University of Tokyo Hospital Department of Radiology

ookumak-rad@h.u-tokyo.ac.jp03-8500-8667

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026